Week18, 2024
1. Seasonal influenza activity is declining nationwide, with 3.1% of clinical respiratory specimens testing positive for influenza.
2. Public health labs identified 70.6% of influenza-positive specimens as Influenza A and 29.4% as Influenza B; Influenza A(H3N2) (53.7%) was slightly more prevalent than A(H1N1)pdm09 (46.3%).
3. The outpatient respiratory illness rate remains at 2.1%, stable for the fifth week and below the national baseline.
4. Six influenza-associated pediatric deaths were reported this week, bringing the season's total to 164.
5. Cumulative influenza hospitalization rates reached 80.3 per 100,000, the second highest recorded for this stage of any season since tracking began.
6. Deaths attributed to influenza accounted for 0.2% of all deaths this week, a stable percentage compared to the prior week.
7. Antiviral susceptibility testing showed high effectiveness, with only minimal reduced inhibition noted in a few isolated cases, mostly in A(H1N1)pdm09 strains.
8. Influenza vaccination is recommended for everyone aged 6 months and older, though no changes in vaccination trends were highlighted.
9. No jurisdictions reported moderate or high levels of ILI activity; all are below baseline, with minimal activity predominant.
10. Co-circulation of multiple respiratory viruses, including COVID-19 and RSV, continues to impact flu activity interpretation, emphasizing the importance of integrated surveillance.